Philips Previews Five-Year Plan As Connected Care Returns Group To Growth In Q3
Executive Summary
COVID-19 business volatility continues to impact the medtech industry, but Royal Philips is targeting modest comparable sales growth for 2020 after posting quarterly growth of 10%.
You may also be interested in...
Philips Strikes Record High Number Of Long Term Health Care Partnership Deals
Royal Philips closed out the first year of COVID-19 with 7% revenue growth in the fourth quarter. CEO Frans van Houten says low single digit growth is the target for fiscal 2021.
HHS Bails Out Of Contract With Royal Philips To Make Ventilators
The US HHS has partially terminated a deal it made in April with Philips to manufacture 43,000 medical ventilators. The contract had been worth a whopping $646.7m.
Philips To Pay $360M For Intact Vascular, Gains Peripheral Vascular Repair Device
Intact Vascular developed the Tack endovascular system to repair vascular dissections following peripheral balloon angioplasty.